Opaleye Management Inc. Pep Gen Inc. Call Options Transaction History
Opaleye Management Inc.
- $418 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PEPG
# of Institutions
52Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$15.8 Million0.26% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.76MShares$4.08 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.51MShares$2.23 Million0.0% of portfolio
-
Viking Global Investors LP1.48MShares$2.19 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.35MShares$2 Million0.0% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $35M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...